Therapeutic implications of bioavailability.
D000287:Administration, Topical; D000700:Analgesics / Q000378:metabolism; D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism; D000890:Anti-Infective Agents / Q000378:metabolism; D000893:Anti-Inflammatory Agents / Q000378:metabolism; D000925:Anticoagulants / Q000378:metabolism; D000927:Anticonvulsants / Q000378:metabolism; D001682:Biological Availability; D001702:Biopharmaceutics; D002301:Cardiac Glycosides / Q000378:metabolism; D004232:Diuretics / Q000378:metabolism; D004358:Drug Therapy; D006801:Humans; D007980:Levodopa / Q000378:metabolism; D013256:Steroids / Q000378:metabolism; D013963:Thyroid Hormones / Q000378:metabolism; D014815:Vitamins / Q000378:metabolism
D000700:Analgesics; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D000927:Anticonvulsants; D002301:Cardiac Glycosides; D004232:Diuretics; D013256:Steroids; D013963:Thyroid Hormones; D014815:Vitamins; D007980:Levodopa